Commonwealth Equity Services’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-342
Closed -$11K 4186
2024
Q1
$11K Buy
+342
New +$8.87K ﹤0.01% 3990
2020
Q4
Sell
-341
Closed -$156K 3282
2020
Q3
$156K Sell
341
-21
-6% -$12.2K ﹤0.01% 2798
2020
Q2
$222K Sell
362
-63
-15% -$34.8K ﹤0.01% 2513
2020
Q1
$202K Sell
425
-9
-2% -$4.89K ﹤0.01% 2391
2019
Q4
$251K Buy
434
+13
+3% +$9.12K ﹤0.01% 2452
2019
Q3
$277K Buy
421
+17
+4% +$14.1K ﹤0.01% 2312
2019
Q2
$312K Buy
404
+22
+6% +$15.5K ﹤0.01% 2169
2019
Q1
$269K Sell
382
-396
-51% -$237K ﹤0.01% 2245
2018
Q4
$364K Buy
778
+384
+97% +$248K ﹤0.01% 1875
2018
Q3
$339K Sell
394
-295
-43% -$213K ﹤0.01% 2066
2018
Q2
$475K Buy
689
+44
+7% +$22.4K ﹤0.01% 1788
2018
Q1
$287K Buy
645
+164
+34% +$79.5K ﹤0.01% 2092
2017
Q4
$212K Sell
481
-599
-55% -$273K ﹤0.01% 2325
2017
Q3
$532K Buy
1,080
+189
+21% +$94.6K ﹤0.01% 1575
2017
Q2
$494K Buy
891
+540
+154% +$343K ﹤0.01% 1579
2017
Q1
$232K Buy
+351
New +$188K ﹤0.01% 2047

Other funds holding TVRD

Commonwealth Equity Services's TVRD Position: Q2 2024 in Review

Commonwealth Equity Services sold out of Tvardi Therapeutics (TVRD) in Q2 2024, closing a stake of 342 shares — an estimated $11K sold.

Commonwealth Equity Services first reported a position in TVRD in Q1 2017 and held it in 16 quarters. The position peaked at $532K in Q3 2017. 79 funds tracked by Wall St. Rank hold TVRD as of Q2 2024.

  • Commonwealth Equity Services reported no remaining Tvardi Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 342 Tvardi Therapeutics shares in Q2 2024, an estimated $11K.
  • Commonwealth Equity Services first reported a position in Tvardi Therapeutics in Q1 2017 and held it in 16 quarters.
  • Commonwealth Equity Services's Tvardi Therapeutics position peaked at $532K in Q3 2017.
  • 79 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2024.

Based on Commonwealth Equity Services's 13F filing for Q2 2024, filed 31 Jul 2024.